Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy
Public ClinicalTrials.gov record NCT01339559. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam Used as Adjunctive Treatment in Subjects Aged 16 Years or Older With Epilepsy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 3, open label, long term follow-up (LTFU), multicenter, noncomparative, and single arm study of brivaracetam (BRV).
Study identification
- NCT ID
- NCT01339559
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 767 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 11, 2011 (Actual)
- Primary completion
- Apr 18, 2019 (Actual)
- Completion
- Apr 18, 2019 (Actual)
- Last update posted
- Aug 17, 2021
2011 – 2019
United States locations
- U.S. sites
- 49
- U.S. states
- 25
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 001 | Phoenix | Arizona | 85004 | — |
| 013 | Phoenix | Arizona | 85006 | — |
| 006 | Tucson | Arizona | 85718 | — |
| 775 | Little Rock | Arkansas | 72205 | — |
| 025 | San Francisco | California | 94115 | — |
| 060 | Aurora | Colorado | 80045 | — |
| 071 | Miami | Florida | 33176 | — |
| 027 | Orlando | Florida | 32819 | — |
| 064 | Port Charlotte | Florida | 33952 | — |
| 023 | Atlanta | Georgia | 30322 | — |
| 048 | Rome | Georgia | 30165 | — |
| 039 | Boise | Idaho | 83702 | — |
| 029 | Chicago | Illinois | 60612 | — |
| 005 | Peoria | Illinois | 61637 | — |
| 017 | Winfield | Illinois | 60190 | — |
| 020 | Ames | Iowa | 50010 | — |
| 069 | Iowa City | Iowa | 52242 | — |
| 780 | Lexington | Kentucky | 40536 | — |
| 008 | Bethesda | Maryland | 20817 | — |
| 068 | Waldorf | Maryland | 20603 | — |
| 009 | Golden Valley | Minnesota | 55422 | — |
| 032 | Lebanon | New Hampshire | 03756 | — |
| 042 | Hamilton | New Jersey | 08619 | — |
| 099 | New York | New York | 10011 | — |
| 022 | New York | New York | 10016 | — |
| 098 | Poughkeepsie | New York | 12601 | — |
| 010 | Asheville | North Carolina | 28806 | — |
| 003 | Durham | North Carolina | 27705 | — |
| 034 | Cleveland | Ohio | 44195 | — |
| 778 | Columbus | Ohio | 43210 | — |
| 070 | Columbus | Ohio | 43215 | — |
| 002 | Toledo | Ohio | 43614 | — |
| 043 | Oklahoma City | Oklahoma | 73112 | — |
| 091 | Oklahoma City | Oklahoma | 73112 | — |
| 054 | Tulsa | Oklahoma | 74136-83 | — |
| 015 | Philadelphia | Pennsylvania | 19107 | — |
| 028 | Charleston | South Carolina | 29425 | — |
| 021 | Port Royal | South Carolina | 29965 | — |
| 776 | Nashville | Tennessee | 37232-25 | — |
| 061 | Austin | Texas | 78758 | — |
| 011 | Dallas | Texas | 75251 | — |
| 777 | Dallas | Texas | 75251 | — |
| 035 | Dallas | Texas | 75390 | — |
| 049 | Houston | Texas | 77025 | — |
| 050 | Mansfield | Texas | 76063 | — |
| 036 | Charlottesville | Virginia | 22908 | — |
| 056 | Spokane | Washington | 99204 | — |
| 052 | Madison | Wisconsin | 53715 | — |
| 057 | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 135 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01339559, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 17, 2021 · Synced Nov 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01339559 live on ClinicalTrials.gov.